Skip to main content

Table 1 Case reports of new-onset myasthenia gravis after vaccination

From: Myasthenia gravis following human papillomavirus vaccination: a case report

Author

Age/Sex

Vaccine Type

Time to onset

Initial symptoms

Treatment

Prognosis

(Time to recovery)

Thymoma

MGFA Class

Biron [9]

48/M

HBV

1 mo after 2nd shot

Ocular

Edrophonium,, plasma exchange, cyclophosphamide, steroid

Improved.

(After 30 PE)

+

I

Bahri [10]

46/F

HBV

1mo after 2nd shot

Ocular, bulbar

Pyridostigmine, steroid

Improved

(Not mentioned)

+

IIb

Takizawa [8]

69/M

BCG

6 wks

Ocular

Pyridostigmine

Improved

(70 days)

–

IIa

Our case

23/F

HPV

3 d after 2nd shot

Ocular, bulbar

Pyridostigmine, steroid, IVIG

Improved

(84 days)

–

V

  1. Mo months, d days, HBV hepatitis B vaccine, BCG Bacillus Calmette-Guerin, HPV human papillomavirus, IVIG intravenous immunoglobulin, MGFA myasthenia gravis foundation of America clinical classification